BMI+
Evidence-Based Resources

Why the number
isn't the whole story.

Standard BMI has been in clinical use since the 1970s. It was never designed to diagnose individuals — it was a population statistics tool. Here's what the research actually says about its limitations, and what better measures exist.

01

Why is standard BMI less accurate for South Asian, East Asian, and African people?

The standard BMI cutoffs — overweight at 25, obese at 30 — came from studies conducted predominantly on European populations. That's not a criticism of the researchers; it reflects who participated in large-scale studies at the time. But metabolism and body composition are not identical across ancestry groups.

Research published in The Lancet and reviewed by a WHO Expert Consultation found that South Asian and East Asian adults develop type 2 diabetes, hypertension, and cardiovascular disease at BMI values 3–5 units lower than European adults. A South Asian person at BMI 23 may already carry the metabolic burden that a European person wouldn't reach until BMI 27.

The IDF, WHO, and national bodies in India, Japan, China, and Singapore now recommend action thresholds of BMI 23 for South and East Asian adults (versus 25 for European adults), and obese at 27.5 (versus 30). BMI+ applies these adjusted cutoffs automatically when you select your ancestry background.

WHO Expert Consultation IDF Guidelines The Lancet
02

What is waist-to-height ratio, and why do researchers say it's a better predictor than BMI?

Waist-to-height ratio (WHtR) is a simple calculation: your waist circumference divided by your height. A result above 0.5 — meaning your waist is more than half your height — signals excess visceral fat accumulation, regardless of total body weight.

Visceral fat is fat stored around and within the abdominal organs. Unlike the fat under your skin, it releases inflammatory compounds and free fatty acids directly into the liver, driving insulin resistance, elevated triglycerides, and cardiovascular disease. You can have a completely normal BMI and still have dangerous levels of visceral fat.

A 2012 meta-analysis in Obesity Reviews covering over 300,000 participants found WHtR outperformed BMI, waist circumference alone, and waist-to-hip ratio in predicting cardiometabolic disease. A widely cited rule of thumb: "keep your waist to less than half your height." Calculate your WHtR with BMI+ →

03

I'm muscular and athletic — why does my BMI say I'm overweight?

BMI is a ratio of weight to height squared. It has no way to tell whether your weight comes from muscle or fat. A kilogram is a kilogram to BMI — which is why it consistently misclassifies athletes, bodybuilders, and people with above-average lean mass as overweight or even obese.

This is often called the BMI paradox. Research has found that many elite athletes — people with exceptional cardiovascular fitness and low body fat — technically qualify as obese by BMI. Meanwhile, some people with normal BMI values carry very little muscle and significant fat, particularly around the abdomen.

If you're muscular, the more useful numbers are your waist-to-height ratio (which doesn't care how much you weigh) and your estimated body fat percentage. BMI+ adds these metrics to give your BMI result the context it actually needs.

04

What BMI thresholds should actually apply to my ethnic background?

Evidence-based adjusted thresholds exist for several ancestry groups. These are not unofficial estimates — they reflect published clinical guidelines:

EUROPEAN / CAUCASIAN

Overweight: ≥25 · Obese: ≥30 · Central obesity (waist): ≥94 cm men, ≥80 cm women

SOUTH ASIAN (Indian, Pakistani, Bangladeshi)

Overweight: ≥23 · Obese: ≥27.5 · Central obesity: ≥90 cm men, ≥80 cm women

EAST / SOUTHEAST ASIAN

Overweight: ≥23 · Obese: ≥27.5 · Central obesity: ≥90 cm men, ≥80 cm women

AFRICAN / AFRO-CARIBBEAN

Standard WHO BMI thresholds apply · Central obesity: ≥94 cm men, ≥80 cm women (IDF)

HISPANIC / LATIN AMERICAN

Overweight: ≥23–25 · Central obesity: ≥90 cm men, ≥80 cm women

05

What is BMR, what is TDEE, and how do I actually use them?

BMR (Basal Metabolic Rate) is the number of calories your body burns at complete rest — just to keep your heart beating, lungs breathing, and organs functioning. Think of it as your idle fuel consumption.

TDEE (Total Daily Energy Expenditure) is your BMR multiplied by an activity factor. If you sit at a desk most days, your TDEE is around 1.2× your BMR. If you train intensively every day, it might be 1.7–1.9×. TDEE is the number that actually matters for weight management — it's what you're burning in real life.

To lose fat steadily, eat 300–500 kcal below your TDEE. That produces roughly 0.25–0.45 kg of fat loss per week — sustainable enough to preserve muscle mass. Larger deficits tend to accelerate muscle loss, which lowers your BMR and makes weight regain more likely. BMI+ calculates both using the Mifflin-St Jeor equation and models how a 300 or 500 kcal deficit would affect your waist-to-height ratio over 90 days.

06

What is central obesity, and why is it more dangerous than general overweight?

Central obesity means carrying excess fat in the abdominal region — specifically visceral fat, which accumulates around the liver, pancreas, intestines, and other organs. It's distinct from subcutaneous fat (the fat you can pinch under your skin), which is far less metabolically harmful.

Visceral fat is biologically active in a damaging way. It continuously releases inflammatory molecules and free fatty acids into the portal vein — which flows directly to the liver. This drives insulin resistance, non-alcoholic fatty liver disease, elevated LDL and triglycerides, and hypertension. All of this can happen at a perfectly normal overall body weight.

This is why waist circumference and WHtR matter. You can't see visceral fat on a scale, but you can approximate its presence through your waist measurement. Reducing waist circumference — through calorie deficit and aerobic exercise in particular — is one of the highest-impact metabolic interventions available.

07

Is a BMI of 24 actually healthy? What does 'normal weight' really mean?

It means your weight-to-height ratio falls within the range statistically associated with lower disease incidence in large European population studies. That's a meaningful signal, but it tells you nothing about where your fat is distributed, what your blood glucose or lipid panel looks like, or whether your ancestry group has different relevant thresholds.

Researchers have documented a phenomenon sometimes called MONW — Metabolically Obese, Normal Weight. An estimated 20–30% of adults with a normal BMI show insulin resistance, elevated triglycerides, high blood pressure, or other metabolic risk markers. They look fine on paper; the underlying biology says otherwise.

A normal BMI is a reasonable starting point. It becomes meaningful when paired with waist measurements, ancestry-adjusted thresholds, and metabolic context. That's the whole point of this tool.

08

How is waist-to-hip ratio different from waist-to-height ratio?

Both measure body fat distribution, but they capture slightly different things.

WHR (waist ÷ hips) identifies whether your fat distribution is android (apple-shaped — more abdominal) or gynoid (pear-shaped — more hip and thigh). Android distribution carries significantly higher cardiovascular risk. The WHO flags high risk at WHR above 0.90 for men and above 0.85 for women.

WHtR (waist ÷ height) accounts for overall frame size. Taller people naturally have larger waist circumferences — dividing by height normalises this. Current evidence slightly favours WHtR as a standalone predictor. Both are useful, and both are calculated by BMI+ when you enter waist and hip measurements.

09

Should we stop using BMI entirely, or does it still serve a purpose?

BMI still has a role. At the population level, it's a useful epidemiological tool — free, instant, reproducible, and reasonably well correlated with disease risk across large groups. The problem is applying a population screening tool as a personal diagnostic — which is exactly what happens in most clinical settings.

Applied to individuals, BMI will produce false positives (flagging fit, muscular people as high risk) and false negatives (missing metabolically unhealthy lean people with abdominal fat). Neither outcome serves the patient.

The sensible position: keep BMI as one signal among several. Add waist circumference, WHtR, ancestry-adjusted thresholds, activity level, and where possible, fasting glucose and lipid panels. That's the philosophy behind BMI+. The number isn't wrong — it's just incomplete on its own.

10

How do I set a realistic and safe weight loss target?

A clinically supported rate of fat loss is 0.25–0.5 kg per week. Going faster than this typically means losing muscle alongside fat, which lowers your BMR and makes long-term weight maintenance harder — not easier.

The calculation is straightforward: if your TDEE is 2,400 kcal, a 500 kcal daily deficit brings you to 1,900 kcal, producing roughly 0.45 kg of weekly fat loss. A 300 kcal deficit is gentler and often more sustainable for people with busy, variable schedules.

A better target than weight alone: bring your waist-to-height ratio below 0.5. This is directly tied to visceral fat reduction — the metabolically significant kind. BMI+ models both 300 kcal and 500 kcal deficit scenarios in its 90-day trajectory simulator, showing how many weeks each approach would take to hit that threshold for your specific measurements. Run your trajectory on BMI+ →

Primary Sources

Every claim on this page is drawn from peer-reviewed research or official clinical guidelines. These are the primary sources.

01

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

WHO Expert Consultation · The Lancet, Vol. 363, Issue 9403 · January 2004

The foundational WHO consultation establishing that Asian populations develop type 2 diabetes and cardiovascular disease at BMI values significantly lower than European-derived thresholds. Proposed action points at BMI 23 and 27.5 for high-risk Asian populations.

The Lancet WHO Expert Consultation Lancet 2004
02

Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis

Ashwell M, Gunn P, Gibson S · Obesity Reviews, Vol. 13 · March 2012 · PubMed: 22106927

Systematic review of 78 studies across 14 countries. WHtR outperformed BMI and waist circumference alone for hypertension, type 2 diabetes, dyslipidaemia, metabolic syndrome, and cardiovascular outcomes. Established the 0.5 boundary value as a suitable global screening threshold.

Obesity Reviews 300,000+ participants PubMed 22106927
03

A systematic review of waist-to-height ratio as a screening tool for cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value

Ashwell M, Gibson S · Nutrition Research Reviews · 2009 · PubMed: 20819243

Earlier systematic review establishing WHtR 0.5 as a universal threshold applicable across sex, age, and ethnicity — including Caucasian, Asian, and Central American populations. The "keep your waist to less than half your height" rule originates here.

Nutrition Research Reviews PubMed 20819243
04

The IDF Definition Is Better Suited for Screening Metabolic Syndrome and Estimating Risks of Diabetes in Asian American Adults

Yeh M-C et al · Nutrients · 2020 · PMC7759813

Using NHANES 2011–2016 data, this study demonstrates that the IDF's ethnicity-specific waist circumference criteria outperform the harmonised ATP III criteria for screening metabolic syndrome and predicting diabetes risk in Asian American adults.

Nutrients IDF Guidelines NHANES 2011–16
05

The "metabolically-obese," normal-weight individual

Ruderman NB, Schneider SH, Berchtold P · The American Journal of Clinical Nutrition · 1981;34(8):1617–21 · PubMed: 7270486

The original paper coining the MONW phenotype. Described patients with type 2 diabetes, hypertension, and hypertriglyceridaemia who were not obese by standard measures, but would benefit from caloric restriction — predating the modern understanding of visceral fat by a decade.

AJCN · 1981 Original MONW Paper PubMed 7270486
06

Metabolic Obesity in People with Normal Body Weight (MONW) — Review of Diagnostic Criteria

Zembrzuski VM et al · International Journal of Environmental Research and Public Health · 2022 · PMC8776153

Comprehensive review of MONW prevalence (ranging from 5% to 45% depending on diagnostic criteria and population), characterising insulin resistance as the central hallmark. Notes higher prevalence in South Asian populations compared to Chinese populations among lean individuals.

IJERPH · 2022 MONW Review PMC8776153
07

Visceral and intrahepatic fat are associated with cardiometabolic risk factors above other ectopic fat depots: The Framingham Heart Study

Linge J et al · Obesity · 2018 · PMC5964004

Framingham Heart Study data showing visceral adipose tissue remains significantly associated with cardiometabolic risk factors even after adjustment for BMI and waist circumference — confirming that fat location, not total mass, is the primary driver of metabolic harm.

Framingham Heart Study Visceral Fat PMC5964004
08

Bias and accuracy of resting metabolic rate equations in non-obese and obese adults

Frankenfield D et al · Journal of the Academy of Nutrition and Dietetics · 2013 · PubMed: 23631843

Head-to-head comparison of predictive equations for resting energy expenditure. The Mifflin-St Jeor equation showed the lowest magnitude of systematic error and greatest accuracy for non-obese adults — the basis for its use as the clinical standard and the equation underlying BMI+.

JAND · 2013 Mifflin-St Jeor PubMed 23631843
Run Your Full Analysis

Ready to see your actual numbers?

Apply all of this in under 60 seconds. Enter your measurements and get a full cardiometabolic profile with ancestry-adjusted thresholds, WHtR analysis, and AI-powered recommendations.

Open the Calculator

FOR INFORMATIONAL PURPOSES ONLY — NOT MEDICAL ADVICE. CONSULT A QUALIFIED CLINICIAN BEFORE MAKING HEALTH DECISIONS.